Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.05 | 1.79 |
NAV | ₹13.34 | ₹18.87 |
Fund Started | 10 Apr 2024 | 10 Apr 2023 |
Fund Size | ₹1788.04 Cr | ₹7133.19 Cr |
Exit Load | Exit load of 0.50%, if redeemed within 30 days. | Exit load of 1%, if redeemed within 12 months. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 4.70% | 2.83% |
3 Year | - | - |
5 Year | - | - |
1 Year
3 Year
5 Year
Equity | 98.89% | 98.00% |
Cash | 1.10% | 1.30% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Eternal Ltd. | 5.18% |
One97 Communications Ltd. | 5.08% |
Astrazeneca Pharma India Ltd. | 3.79% |
Bajaj Finserv Ltd. | 3.33% |
BlackBuck Ltd. | 2.62% |
Jubilant Ingrevia Ltd. | 2.59% |
GE Vernova T&D India Ltd. | 2.56% |
Reliance Industries Ltd. | 2.32% |
Info Edge (India) Ltd. | 2.29% |
Varun Beverages Ltd. | 2.27% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 4.98% |
Bharti Airtel Ltd. - (Partly Paid up Equity Shares (Rights Issue)) | 4.65% |
Infosys Ltd. | 4.23% |
Reliance Industries Ltd. | 3.38% |
Axis Bank Ltd. | 3.24% |
Info Edge (India) Ltd. | 3.08% |
Maruti Suzuki India Ltd. | 3.00% |
Sun Pharmaceutical Industries Ltd. | 2.97% |
Pidilite Industries Ltd. | 2.81% |
Mahindra & Mahindra Ltd. | 2.72% |
Name | Prateek Poddar | Vaibhav Dusad |
Start Date | 07 Jun 2024 | 18 Nov 2024 |
Name
Start Date
Description | The Scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies following innovation theme. | The scheme seeks to generate long term capital appreciation by predominantly investing in equity & equity related securities of companies and units of global mutual funds/ETFs that can benefit from innovation strategies and theme. |
Launch Date | 10 Apr 2024 | 10 Apr 2023 |
Description
Launch Date